Search Results for: raoult

Weekend reads: JAMA editor resigns after review of podcast on racism and medicine; ‘Please Commit More Blatant Academic Fraud’; machine learning’s health credibility crisis

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Two transcendental meditation papers retracted for failures to report primary … Continue reading Weekend reads: JAMA editor resigns after review of podcast on racism and medicine; ‘Please Commit More Blatant Academic Fraud’; machine learning’s health credibility crisis

Weekend reads: Hydroxychloroquine champion faces ethics charges; a serial plagiarist in philosophy; another author reaches 100 retractions

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Journals flag concerns in three dozen papers by nutrition researchers … Continue reading Weekend reads: Hydroxychloroquine champion faces ethics charges; a serial plagiarist in philosophy; another author reaches 100 retractions

Weekend reads: Steak-umm in the scientific literature; hushed-up COVID-19 data; major award cancelled for 2020

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: An exclusive about a case of misconduct at the University … Continue reading Weekend reads: Steak-umm in the scientific literature; hushed-up COVID-19 data; major award cancelled for 2020

Co-author of controversial hydroxychloroquine study has 2018 paper corrected for “unintentional mistake”

Didier Raoult, whose claims that hydroxychloroquine can treat COVID-19 have been widely disputed, has had a 2018 paper corrected for what his team says was unintentional duplication of a figure. Here’s the correction for “Identification of rickettsial immunoreactive proteins using a proximity ligation assay Western blotting and the traditional immunoproteomic approach,” which came four months … Continue reading Co-author of controversial hydroxychloroquine study has 2018 paper corrected for “unintentional mistake”

French hydroxychloroquine study has “major methodological shortcomings” and is “fully irresponsible,” says review, but is not being retracted

A March 2020 paper that set off months of angry debates about whether hydroxychloroquine is effective in treating COVID-19 has “gross methodological shortcomings” that “do not justify the far-reaching conclusions about the efficacy of hydroxychloroquine in Covid-19,” according to a review commissioned by the journal that published the original work. The comments, by Frits Rosendaal, … Continue reading French hydroxychloroquine study has “major methodological shortcomings” and is “fully irresponsible,” says review, but is not being retracted

French hydroxychloroquine-COVID-19 study withdrawn

The authors of a preprint on use of hydroxychloroquine — the controversial drug heavily promoted by, and now apparently taken by, President Trump, at least for a few more days — along with azithromycin for COVID-19 have withdrawn the paper. The preprint, “Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 … Continue reading French hydroxychloroquine-COVID-19 study withdrawn

Weekend reads: Revelations about a controversial COVID-19 study; weaponizing uncertainty; a ‘super-spotter’ of duplicated images

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. Sending thoughts to our readers and wishing them the best in this uncertain time. The week … Continue reading Weekend reads: Revelations about a controversial COVID-19 study; weaponizing uncertainty; a ‘super-spotter’ of duplicated images

Elsevier investigating hydroxychloroquine-COVID-19 paper

Elsevier has weighed in on the handling of a controversial paper about the utility of hydroxychloroquine to treat Covid-19 infection, defending the rigor of the peer review process for the article in the face of concerns that the authors included the top editor of the journal that published the work.  On April 3, as we … Continue reading Elsevier investigating hydroxychloroquine-COVID-19 paper

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement of concern from the society that publishes the journal in which the work appeared.  The April 3, 2020, notice, from the International Journal of Antimicrobial Agents, states that the … Continue reading Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

Meet the scientific sleuths: More than two dozen who’ve had an impact on the scientific literature

Over the years, we have written about a number of the sleuths who, on their own time and often at great risks to their careers or finances, have looked for issues in the scientific literature. Here’s a sampling: